Home › Endometrial Cancer › Tennessee › Chattanooga
Endometrial Cancer clinical trials in Chattanooga, TN
3 studies for Endometrial Cancer are looking for participants at sites in and around Chattanooga (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RecruitingPhase 3
- Erlanger Medical Center ( Site 5009), Chattanooga
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RecruitingPhase 1/2
- Erlanger Health, Inc, Chattanooga
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
RecruitingPhase 1/2
- Tennessee Oncology, PLLC, Chattanooga
Endometrial Cancer trials in other cities
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Chicago, IL25 studies
- Columbus, OH25 studies
- Queens, NY25 studies
Other studies in Chattanooga
- Non-Small Cell Lung Cancer11 studies
- Myasthenia Gravis6 studies
- Metastatic Cancer6 studies
- Ovarian Cancer5 studies
- Steatotic Liver Disease4 studies
- Chronic Kidney Disease4 studies
- Lung Cancer4 studies
- Ischemic Stroke4 studies
- Melanoma4 studies
- Diabetes4 studies
- Colorectal Cancer4 studies
- COPD3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.